发明名称 |
Methods and tools for identifying compounds which modulate atherosclerosis by impacting ldl-proteoglycan binding |
摘要 |
The present invention relates to the study and control of atherosclerosis through the modulation of LDL-proteoglycan binding at Site B (amino acids 3359-3369) of the apo-B100 protein in LDL. The invention encompasses methods of identifying compounds which modulate LDL-proteoglycan binding, methods of identifying compounds which modulate atherosclerotic lesion formation, and methods of modulating the formation of atherosclerotic lesions. The invention also encompasses mutant apo-B100 proteins and LDL which exhibit reduced proteoglycan binding while maintaining LDL-receptor binding, polynucleotides which encode these apo-B100 proteins, as well as cells and animals which express the mutant apo-B100 proteins. |
申请公布号 |
AU2984299(A) |
申请公布日期 |
1999.09.27 |
申请号 |
AU19990029842 |
申请日期 |
1999.03.05 |
申请人 |
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, |
发明人 |
THOMAS LLOYD INNERARITY;JAN OLOF SOLVE BOREN |
分类号 |
G01N33/92 |
主分类号 |
G01N33/92 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|